Chinese patent medicine for treating myasthenia gravis and asthenia of livers and kidneys and method for manufacturing Chinese patent medicine

Abstract

The invention provides Chinese patent medicine for treating myasthenia gravis and asthenia of livers and kidneys and a method for manufacturing the Chinese patent medicine. The Chinese patent medicine which is a traditional Chinese medicine composition comprises, by weight, 10-20 parts of angelica sinensis, 5-15 parts of radix ginseng rubra, 2-6 parts of schisandra chinensis, 10-25 parts of paederia scandens, 6-13 parts of endothelium corneum gigeriae galli, 3-12 parts of immature bitter oranges, 2-9 parts of dried tangerine or orange peel, 30-55 parts of astragalus, 2-7 parts of turtle shells, 10-20 parts of oysters, 10-20 parts of nacre mother of pearl and 5-20 parts of polygonum cuspidatum. The method for manufacturing the Chinese patent medicine includes smashing the angelica sinensis, the radix ginseng rubra, the schisandra chinensis, the paederia scandens, the endothelium corneum gigeriae galli, the immature bitter oranges and the dried tangerine or orange peel to obtain medicine powder; mixing the astragalus, the turtle shells, the oysters, the nacre mother of pearl and the polygonum cuspidatum with one another, decocting the astragalus, the turtle shells, the oysters, the nacre mother of pearl and the polygonum cuspidatum in water to obtain medicine liquid and concentrating the medicine liquid to obtain clear paste; mixing the medicine powder with the clear paste to obtain mixtures, and manufacturing pills from the mixtures. The Chinese patent medicine and the method have the advantages that the traditional Chinese medicine composition can be used for treating the myasthenia gravis and the asthenia of the livers and the kidneys and is free of toxic and side effects, low in treatment cost and short in course of treatment, the total effective rate can reach 100%, the method is simple, and the like.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a Chinese patent medicine for treating myasthenia gravis with liver and kidney deficiency syndrome and a preparation method thereof. Background technique [0002] Myasthenia gravis, progressive muscular dystrophy, motor neuron disease, Guillain-Barré syndrome, multiple sclerosis, sequelae of children's anesthesia and other diseases have become recognized in the medical field today due to their high morbidity and mortality rates and difficult treatment. Intractable diseases. [0003] Chinese medicine refers to the above-mentioned diseases as "atrophy disease". Atrophy refers to internal injuries of the viscera and lack of nourishment of the tendons of the limbs, resulting in sluggishness of the tendons and veins of the limbs, weakness, prolonged use, and even muscle atrophy or paralysis as the main clinical manifestations. The name of the disease was first seen in th...

AI Technical Summary

Problems solved by technology

[0008] Conventional treatment methods for flaccidity syndrome in modern medicine can be roughly divided into the following three types: ①Surgery, that is, removal of the thymus gland or thymoma. And aggravated; ② Taking anticholinesterase drugs, immunosuppressants, hormones, etc., although the disease can be alleviated, long-term medication will lead to the destruction of acetylcholine receptors in the body, and the disease will become more stubborn; ③ Plasma exchange is generally only used for For patients with serious conditions, the cost is expensive and the maintenance time is short, only about 7 to 15 days

Images